PAOG (PAO Group) EBITDA Margin %: 0.00% (As of . 20)


What is PAO Group EBITDA Margin %?

PAO Group PAOG EBITDA Margin % is 0.00% as of . 20.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PAO Group's EBITDA for the three months ended in . 20 was $0.00 Mil. PAO Group's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, PAO Group's EBITDA margin for the quarter that ended in . 20 was 0.00%.

PAO Group  (OTCPK:PAOG) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PAO Group EBITDA Margin % Related Terms

PAO Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for PAO Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PAO Group EBITDA Margin % Chart

PAO Group Annual Data
Trend
EBITDA Margin %

PAO Group Quarterly Data
EBITDA Margin %

PAOG vs MIHI, LMNK, TONJ: EBITDA Margin % Comparison

For the Medical Care Facilities subindustry, PAO Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PAO Group EBITDA Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PAO Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PAO Group's EBITDA Margin % falls into.


PAO Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PAO Group's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

PAO Group's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
PAO Group (PAOG) has a EBITDA Margin % of 0.00% as of . 20. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PAO Group and its competitors.
Is PAO Group's EBITDA Margin % too high?
PAO Group's current EBITDA Margin % is 0.00%.
How does PAO Group's EBITDA Margin % compare to MIHI and LMNK?
PAO Group's EBITDA Margin % of 0.00% can be compared against companies in the Healthcare Providers & Services industry. The industry median EBITDA Margin % is 10.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PAO Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PAO Group's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PAO Group stock overvalued right now?
PAO Group (PAOG) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For PAO Group (PAOG), the current EBITDA Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PAO Group Business Description

Address 3535 Executive Terminal Drive, Suite 110, Henderson, NV, USA, 89052
PAO Group Inc. is a United States-based holding company. It seeks to develop, acquire, partner with, or participate in companies and concepts in the development and launch of alternative medicine clinics focused on non-traditional patient care solutions. The range of treatment solutions includes cannabis, acupuncture, chiropractic, biofeedback, and other solutions, depending on patient needs.